Pharmacokinetic Response to BPI in Burns

NCT00462904 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Xoma to no longer supply drug for the study

Conditions

Burns

Interventions

DRUG: BPI

Sponsor

University of Texas Southwestern Medical Center